Joel Coles

Partner specialising in intellectual property litigation. He is an experienced patent litigator who has worked on a number of the recent leading cases in the pharmaceutical and biotechnology fields. His strong life sciences background has been of particular relevance for his recent work relating to pharmaceutical, biotechnology and healthcare technologies, including vaccines, small molecule drugs, biologics, DNA sequencing, and genetic engineering. In particular, Joel has represented clients before the High Court, Court of Appeal and Supreme Court in two of the leading cases relating to the validity and infringement of second medical use (Warner-Lambert v Actavis) and biotechnology patents (Regeneron v Kymab). He has also worked on a number of electronics and mechanical engineering patent cases, and has experience of handling multi-jurisdictional patent actions. In addition to representing clients in litigation before the UK Patents Court, Court of Appeal and Supreme Court, Joel has represented clients in European Patent Office opposition proceedings, and advises on patent litigation strategies, freedom to operate, and patent term extensions, including supplementary protection certificates. · Powell Gilbert LLP

EnglandIntellectual Property, Patent Litigation

Email Call Website

About

Partner at Powell Gilbert LLP specialising in intellectual property and patent litigation with extensive experience in pharmaceuticals, biotechnology, healthcare technologies, electronics and mechanical engineering. He has acted in the UK Patents Court, High Court, Court of Appeal and Supreme Court, represented clients in European Patent Office opposition proceedings, and advises on patent litigation strategy, freedom to operate and patent term extensions including SPCs.

Practice areas

Intellectual PropertyPatent LitigationPatentsLife SciencesPharmaceuticals & BiotechnologyEPO Opposition ProceedingsPatent Strategy & Freedom to OperateSupplementary Protection Certificates

Office

England

Powell Gilbert LLP · Partner specialising in intellectual property litigation. He is an experienced patent litigator who has worked on a number of the recent leading cases in the pharmaceutical and biotechnology fields. His strong life sciences background has been of particular relevance for his recent work relating to pharmaceutical, biotechnology and healthcare technologies, including vaccines, small molecule drugs, biologics, DNA sequencing, and genetic engineering. In particular, Joel has represented clients before the High Court, Court of Appeal and Supreme Court in two of the leading cases relating to the validity and infringement of second medical use (Warner-Lambert v Actavis) and biotechnology patents (Regeneron v Kymab). He has also worked on a number of electronics and mechanical engineering patent cases, and has experience of handling multi-jurisdictional patent actions. In addition to representing clients in litigation before the UK Patents Court, Court of Appeal and Supreme Court, Joel has represented clients in European Patent Office opposition proceedings, and advises on patent litigation strategies, freedom to operate, and patent term extensions, including supplementary protection certificates.

England

Expertise

PharmaceuticalsBiotechnologyHealthcare technologiesVaccinesSmall molecule drugsBiologicsDNA sequencingGenetic engineeringElectronicsMechanical engineeringMulti‑jurisdictional patent actionsEuropean Patent Office opposition proceedingsSupplementary Protection Certificates / patent term extensions

Education

MBiochem (Biochemistry), Oxford University
PhD (Biochemistry), Cambridge University
LLB, BPP Law School
Diploma in Intellectual Property Law and Practice, Oxford University

Admissions

Qualified Solicitor (England & Wales), 2011
Solicitor (Ireland), 2016
UPC Representative, 2023